ALLIQUA BIOMEDICAL INC's ticker is ALQA and the CUSIP is 019621200. A total of 39 filers reported holding ALLIQUA BIOMEDICAL INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $213,000 | +227.7% | 583,339 | +229.8% | 0.00% | – |
| Q2 2017 | $65,000 | -71.4% | 176,891 | -60.7% | 0.00% | – |
| Q1 2017 | $227,000 | -9.9% | 449,715 | +5.3% | 0.00% | – |
| Q4 2016 | $252,000 | -36.4% | 427,072 | -15.8% | 0.00% | – |
| Q3 2016 | $396,000 | -32.5% | 507,408 | -3.2% | 0.00% | – |
| Q2 2016 | $587,000 | +38.1% | 524,296 | +1.1% | 0.00% | – |
| Q1 2016 | $425,000 | -56.0% | 518,516 | +14.7% | 0.00% | – |
| Q4 2015 | $967,000 | -99.5% | 451,996 | -91.7% | 0.00% | -100.0% |
| Q3 2015 | $186,963,000 | +9160.2% | 5,447,760 | +1322.1% | 0.01% | – |
| Q2 2015 | $2,019,000 | +86.4% | 383,083 | +83.9% | 0.00% | – |
| Q1 2015 | $1,083,000 | +40.3% | 208,353 | +43.0% | 0.00% | – |
| Q4 2014 | $772,000 | +10.8% | 145,653 | +1.3% | 0.00% | – |
| Q3 2014 | $697,000 | +2.8% | 143,778 | +16.7% | 0.00% | – |
| Q2 2014 | $678,000 | -34.4% | 123,234 | +0.5% | 0.00% | – |
| Q1 2014 | $1,034,000 | – | 122,634 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PURA VIDA INVESTMENTS, LLC | 583,026 | $466,000 | 0.14% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 1,264,101 | $1,011,000 | 0.14% |
| Perceptive Advisors | 1,921,951 | $1,537,000 | 0.10% |
| Tekla Capital Management LLC | 1,650,000 | $1,287,000 | 0.05% |
| SABBY MANAGEMENT, LLC | 1,321,726 | $1,031,000 | 0.04% |
| J. Goldman & Co LP | 540,000 | $432,000 | 0.02% |
| Chicago Partners Investment Group LLC | 6,453 | $5,000 | 0.00% |
| Edge Wealth Management LLC | 4,930 | $4,000 | 0.00% |
| Janney Montgomery Scott LLC | 98,000 | $78,000 | 0.00% |
| US BANCORP \DE\ | 181,732 | $145,000 | 0.00% |